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Article points
1. A quality improvement 
initiative has been developed 
in Northern Ireland that 
includes a podiatry regional 
training programme. 
2. The programme aimed to 
standardise the assessment 
and diagnosis of peripheral 
arterial disease and 
peripheral neuropathy. 
3. The programme has placed 
safety and the delivery 
of high-quality care at 
the top of the agenda. 
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The standardisation of diabetic foot ulceration assessment and management is 
important. A quality improvement initiative incorporating regional training for 227 
podiatrists was completed in Northern Ireland to standardise the assessment and 
diagnosis of peripheral arterial disease and peripheral neuropathy. The SINBAD 
diabetic foot classification system and risk assessment were also included in podiatry 
practice. Response rates for pre- and post-training questionnaires were high at 85% 
(n=194) and 76% (n=173). The majority (99%, n=191) of respondents listed pulses, 
Doppler sounds and ABPI results as important in vascular assessment and 70% (n=108) 
stated they had learnt new information about Doppler sounds, ABPI technique (83%; 
n=108), clinical signs and symptoms (72%; n=125) and their differential diagnosis 
(33%, n=51). The Edinburgh Claudication Questionnaire was new for 36.4% (n=63). 
The correct use of the Neurotip™ and neurothesiometer in neurological assessment 
was new for 56.6% (n=63) and 43.4% (n=75) attendees respectively. The interpretation 
of results was a key learning area for 81% (n=140). Respondents used the SINBAD 
classification system (65%; n=112) and a risk assessment tool (74%; n=128) in practice. 
This project has placed safety and the delivery of high-quality care to service users at 
the centre of podiatry practice in the region. 
H ealthcare professionals recognise that diabetes and diabetic foot ulceration (DFU) are increasingly important 
global health issues. Northern Ireland has a 
population of 1.8 million and an annual DFU 
incidence of 4.6% (Guidelines and Audit 
Implementation Network [GAIN], 2016). A 
retrospective regional audit of DFU management 
provided baseline information on assessment and 
clinical management in 100 patients presenting 
with a new DFU in 2013/14 (GAIN, 2016). 
Results showed that the assessment of vascular and 
neurological status, risk and appropriate review fell 
below expected national targets. 
In order to address inequalities in and improve 
quality of care for this vulnerable group, a quality 
improvement initiative was developed that 
included a podiatry regional training programme. 
This programme aimed to standardise the 
assessment and diagnosis of peripheral arterial 
disease (PAD) and peripheral neuropathy (PN) 
across Northern Ireland. The SINBAD diabetic 
foot classification system was reviewed and risk 
assignment and timely review considered. 
Methods
Quality improvement is defined as the 
application of a systematic approach that uses 
specific techniques to improve quality (Health 
Foundation, 2014). This quality improvement 
initiative was developed using the Quality 2020 
Attributes Framework (2010), which indicates 
that any clinical intervention should be safe, 
effective, efficient, timely, equitable and patient-
centred. The framework also recognised the 
importance of the Berwick Principles in modern 
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healthcare (Berwick, 2013): 
1. Place safety and quality above all other things.
2. Engage, empower and listen to patients at all 
times.
3. Grow and develop staff to improve the way 
they work.
4. Embrace transparency and openness in all areas 
of work.
The Plan-Do-Study-Act (PDSA) 
methodological approach was adopted, 
recognising the importance of the principles 
described above (Institute for Healthcare 
Improvement, 2018 ).
A regional task and finish group consisting 
of podiatrists from each of the five Trusts in 
Northern Ireland was convened. Sub-groups were 
established to review the best research evidence 
on neurological and vascular assessment of the 
diabetes foot and risk assignment. The SINBAD 
classification system was reviewed and adopted 
(Ince et al, 2007; 2008). 
Results 
Findings are reported using the framework of the 
Berwick Principles.
Safety and quality
The regional task and finish groups presented 
results from a literature review on neurological 
and vascular assessment of the diabetes foot, 
on various wound classification systems and 
models of risk stratification (Leng and Fowkes, 
1992; Jeffcoate et al, 1993; Armstrong et al, 
1998; Treece et al, 2004; Beckert et al, 2006; 
Ince et al, 2007; Prompers et al, 2007; Abbas et 
al, 2008; Ince et al, 2008; Foot Risk Awareness 
and Management Education, 2011; Brownrigg 
et al, 2012; Crawford et al, 2015; Pop-Busui 
et al, 2017).
Agreement was reached on how all NHS 
podiatrists would complete diabetic foot 
assessments, diagnose PAD and PN, allocate 
a SINBAD score and ultimately assign a risk to 
those patients with foot wounds. 
In total, 227 podiatrists attended the training 
sessions. Of these, 194 (85.4%) completed the 
initial knowledge questionnaire and 173 (76.2%) 
completed the post-training questionnaire. The 
reason for separating the results was to enable 
each Trust to address their own particular issues 
in their local implementation plan.
When asked to list three important areas 
of vascular assessment, 99.1% (n=191) of 
respondents stated that pulses, Doppler sounds 
and ABPI results were important (Figure 1). 
Clinical signs and symptoms of PAD and/
or cardiovascular disease were described as 
important by 72.7% (n=140) and the presence of 
intermittent claudication (IC) or rest pain listed 
by 16.7% (n=32).
Respondents regarded establishment of 
vibration perception thresholds (55.5%, n=107), 
diagnosis of painful neuropathy (49.3%, 
Figure 1. Important areas of vascular assessment listed by attendees prior to training. PAD = 
peripheral arterial disease.
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Figure 2. Important areas of neurological assessment listed by attendees prior to training. 
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n=95) and standardisation of the use of the 
10 g monofilament (62.9%, n=121) and the 
Neurotip™ (30.8%, n=59) as important in 
diabetes foot assessment (Figure 2). 
The SINBAD classification system was 
formally adopted to enable clinicians to begin 
to predict outcomes for healing (Ince et al, 
2007; 2008). Participants were asked if they 
were aware of this system and if they used it in 
clinical practice. Clinicians in Trust A all stated 
they were aware of this system and 65% (n=47) 
currently used it in practice. In Trusts B, C, D 
and E, there was an awareness of the SINBAD 
system, but training had not yet been delivered 
locally to allow the system to become embedded 
into clinical practice (Figure 3). 
Attendees were asked if they used a risk 
assessment tool in their practice and how risk was 
assigned to patients. Of the 194 respondents, 168 
(86.6%) reported that they used a risk assessment 
tool, 15 (7.7%) did not use a tool and 11 (5.7%) 
did not respond. Following the training session, 
attendees were asked to identify areas of learning 
or new knowledge. 
Attendees highlighted learning in five areas 
of vascular assessment. Of those who returned 
questionnaires after the training (n=173), 70.5% 
(n=122) stated they had learnt new information 
about the importance of Doppler sounds relating 
to blood f low. ABPI technique had some new 
learning for 83.3% (n=144), as had the use of 
capillary filling time as an unreliable marker of 
PAD for 35 respondents (20%). The Edinburgh 
Claudication Questionnaire was new learning 
for 36.4% (n=63) of respondents and how to 
make a differential diagnosis of PAD, critical 
limb ischaemia, intermittent claudication and the 
influence of peripheral neuropathy was new for 
33.5% (n=58).
The key areas of learning on the neurological 
assessment of the diabetic foot centred on the 
correct use of diagnostic tools and interpretation 
of results. The use of the Neurotip™ and 
neurothesiometer were identified as new learning 
by 56.6% (n=98) and 43.4% (n=75), respectively. 
The interpretation of results was a key learning 
area for 81% (n=140) of respondents. Twenty 
respondents (11.5%) stated they were unaware of 
the patient’s responsibility to inform the DVLA 
of the presence of PN. Fourteen attendees (8%) 
identified the challenges of interpreting and 
recording results in vulnerable patients.
New learning associated with the SINBAD 
classification system included: 
• How and when to use SINBAD (49.7%; n=86).
• Information on scoring wounds, identifying the 
target wound and predicting outcome (63.5%; 
n=110).
• Recording initial and end scores in wound 
assessment (23.1%; n=40).
• Recording SINBAD scores in clinical notes 
Figure 3. Knowledge and use of the SINBAD classification system by attendees.
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Figure 4 Areas of learning relating to vascular assessment identified by attendees.
CLI = critical limb ischaemia; IC = intermittent claudication; PAD = peripheral arterial disease; 
PN = peripheral neuropathy.
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(21.2%; n=37).
• Limitations of the SINBAD system (does not 
assess deep tissue damage/ wound deterioration/ 
provide a treatment plan – 16.8%; n=29).
• Wound measurement (4%; n=7).
The criteria for a regional agreement on 
diagnosis of PAD and IC and on diagnosis of PN 
were highlighted as new learning by 50% (n=87) 
of respondents. The importance of the SINBAD 
classification system as a predictor of outcome was 
identified by 32% (n=55). There is further work 
to be carried out regionally on the risk assessment 
tool, and following this, there will be training for 
staff prior to implementation.
Engage, empower and listen to patients 
The regional DFU audit and the regional training 
programme is supported by Diabetes UK and the 
Diabetes UK Champions Programme. This gives a 
patient voice and ensures that patients are involved 
in projects and in the dissemination of results. 
This work has helped address inequalities in care 
and will ultimately raise the standard of care 
within the region.
Grow and develop staff 
Podiatrists from the task and finish sub-groups 
were given the opportunity to appraise the latest 
research evidence, apply results to clinical practice 
using the PDSA cycle. They gained confidence 
in evidence appraisal, their decision-making 
and were able to justify their rationale when 
questioned while disseminating information to the 
regional podiatry workforce. 
Embrace transparency and openness
All Trusts were transparent in the challenges they 
faced in service delivery and worked together to 
seize the opportunity to enhance the quality of 
care across the region. Results from the regional 
DFU audit were presented and published locally 
and nationally. Results were also provided to 
all stakeholders involved in the commissioning 
process and to the Department of Health. 
Discussion
The need to standardise clinical assessment and 
DFU management in order to address inequalities 
of care in Northern Ireland is recognised. To 
achieve this, a regional training programme was 
developed using the Berwick Principles and the 
PDSA cycle. The key aim of the programme was 
to standardise the assessment and diagnosis of 
PAD and PN and embed the SINBAD diabetic 
foot classification system into podiatry practice. 
Risk assignment was also considered.  
In total, 227 podiatrists attended the regional 
training programme. Questionnaire response 
Figure 5. Areas of learning relating to neurological assessment identified by attendees.
PN = peripheral neuropathy; VPT = vibration perception threshold.
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Figure 6. Areas of learning relating to the SINBAD classification system identified by attendees.
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rates were high and the training was well 
received. Historically, evidence-based diabetic 
foot assessment has been part of clinical practice 
for almost 20 years through the development 
and implementation of the CREST guidelines 
in 1998. These include the use of ABPIs as a 
diagnostic tool for PAD. This may explain why 
99.1% (n=191) of respondents listed pulses, 
Doppler sounds and ABPI results as important 
in their vascular assessment (Figure 1). However, 
70.5% (n=122) stated they had learnt new 
information around the importance of Doppler 
sounds, particularly monophasic sounds. A 
revision of ABPI technique had some new 
learning for 83.3% (n=144) of respondents, and 
this was important new information for 20% 
(n=35). Clinical signs and symptoms of peripheral 
arterial disease were described as important by 
72.7% (n=126) of respondents, as expected.
The presence of claudication or rest pain was 
listed by 16.7% (n=32) of attendees as important 
in a vascular assessment. However, the use of 
the Edinburgh Claudication Questionnaire as 
a diagnostic tool and the influence of peripheral 
neuropathy on PAD were both highlighted as new 
learning by a third of attendees. 
The importance of neurological assessment 
of the diabetic foot centres on the correct use of 
diagnostic tools and interpretation of results. As 
expected, clinicians listed vibration perception 
thresholds, diagnosis of painful neuropathy 
and standardisation of the use of the 10g 
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monofilament and the Neurotip as important. 
New learning on the use of the Neurotip and 
neurothesiometer was important for 56.6% 
(n=98) and 43.4% (n=75) respectively. The 
interpretation of results was a key learning 
area for most attendees, specifically around the 
assessment of vulnerable patients.
The regional DFU audit (2016) showed that 
implementation of a DFU classification system 
was necessary. Clinicians in Trust A who had 
undergone preliminary training were all aware 
of the SINBAD classification system and 65% 
(47 perople working in Trust A) currently used it 
in practice. In contrast, staff in the other Trusts 
had yet to receive this training, although some 
of them were using SINBAD. A number of areas 
of new learning were identified by attendees; 
these included the appropriate use of SINBAD, 
scoring wounds, wound measurement, record 
keeping and the limitations of SINBAD. Further 
local teaching and review of the implementation 
process is planned and will be re-audited in 
due course. 
It was evident that variation in risk tool 
development and implementation existed across 
Trusts. Work is ongoing to achieve a regional risk 
tool that can standardise and assign risk to people 
with diabetes. 
Conclusion
This training programme has placed safety and 
the delivery of high-quality care at the top of 
the agenda. Successful collaboration between 
podiatry services has facilitated open and 
transparent patient care and helped to address 
the challenges associated with it. Importantly, 
we have engaged, inspired and supported the 
regional podiatry workforce to deliver improved 
outcomes and experience for our service users.  n
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